Physician profile

Miriam Mackovic-Basic

Obstetrics & Gynecology · Lakewood, CA

NPI 1548286016

$12,624.02

in general payments reported to CMS, 2019-2025

13 companies · $12K in 2025

The $12K reported for 2025 was more than what 99% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Debt Forgiveness$11,721.72

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Olympus America INC. $11,721.72 2025
Abbvie INC. $203.46 2021
Minerva Surgical, INC $201.42 2019-2020
Allergan, INC. $148.84 2019-2020
Therapeuticsmd, INC. $117.36 2019-2022
Bayer Healthcare Pharmaceuticals INC. $75.03 2019-2022
Merck Sharp & Dohme LLC $40.13 2020-2021
Lupin INC. $32.87 2019
Organon LLC $22.22 2022
Duchesnay USA Incorporated $19.42 2019
Mayne Pharma Commercial LLC $15.82 2022
Avion Pharmaceuticals $13.85 2019
Exeltis, USA INC. $11.88 2020

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Miriam Mackovic-Basic

$12,624.02

in general payments reported 2019-2025

Years
2019-2025
Top company
Olympus America INC.
Context
The $12K reported for 2025 was more than what 99% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).

https://glasscript.com/doctor/116044/miriam-mackovic-basic

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.